Article: United States: Bio-Imaging to Acquire etrials Worldwide.

Byline: sanjayc03

Bio-Imaging Technologies, Inc., which does business as BioClinica, and etrials Worldwide, jointly announce Bio-Imaging's intent to acquire etrials.

The proposed acquisition is expected to be consummated through a tender offer for all of the outstanding shares of etrials stock. For each share of etrials stock, shareholders will receive 0.124 shares of newly issued Bio-Imaging common stock, 0.076 shares of newly issued Bio-Imaging preferred stock, and $0.15 in cash, which equates to a value of $0.9068 per share for etrials, representing a 27 percent premium to the average closing price for the past thirty days. Stockholders owning ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!